Bardy Diagnostics
Bardy Diagnostics develops ambulatory ECG monitoring solutions, including the Carnation Ambulatory Monitor (CAM) Patch, which is a lightweight, extended-wear cardiac patch monitor designed to optimize P-wave signal capture for more accurate arrhythmia detection. Its products are used by healthcare professionals to obtain clear and actionable cardiac event data for patient diagnosis and management. The organization aims to improve the quality and accuracy of ambulatory cardiac monitoring to support better patient outcomes.
Facts
- HQ
- Seattle
- Sectors
- Medical devices, Healthcare technology, Cardiology diagnostic devices, Patient monitoring
- Founded
- 2013
- Type
- Corporation Seattle business license
- Registered name
- Bardy Diagnostics Inc Seattle business license
- Stage
- former-startup
- Members see funding amounts. .
- Founders
- Gust H. Bardy, M.D.
Is this your organization? Claim it
Bardy Diagnostics Reveals $375M Total Funding; $36M Series B Recorded in April 2019
Bardy Diagnostics, headquartered in New Providence, NJ, has disclosed $375M in total funding, with its latest recorded round a $36M Series B in April 2019. The company’s leadership links to Baxter International via Andrew Hider, and investors include River Cities Capital Funds, HealthQuest Capital, Aperture Venture Partners, and others.
Hillrom to complete $367M acquisition of Bardy Diagnostics after Delaware judge orders deal to proceed
Hillrom will proceed with its previously announced $367 million acquisition of Seattle startup Bardy Diagnostics after a Delaware judge ordered the deal to close following a dispute over sharp Medicare reimbursement cuts that briefly led Hillrom to try to withdraw.
Hillrom to Buy Bardy Diagnostics for $375M, Deal to Close in Q2 with Possible Milestone Payments
Hillrom will acquire Seattle-based Bardy Diagnostics for $375 million, adding Bardy’s week-long CAM cardiac monitor and related cardiology products to its portfolio; the deal may include future milestone payments and is expected to close in Q2. Bardy, founded in 2013, has about $30 million in annualized revenue, over $20 million in net operating losses, roughly 230 employees, and has raised more than $71 million to date.
By Bardy Diagnostics
BardyDx Solicits Newsletter Sign-ups, Promises Privacy and Internal-Use of Submitted Contact Information
BardyDx invites readers to subscribe to an email list for updates, assuring that submitted information is for internal use only and will not be shared, sold, or distributed.
People
-
Gust Bardy Founder
Online
Questions about Bardy Diagnostics
What is Bardy Diagnostics?
bardydx.com
Who are the people behind Bardy Diagnostics?
Seattle Flow lists Gust Bardy (Founder) at Bardy Diagnostics.
Who invested in Bardy Diagnostics, and how much has it raised?
Members of Seattle Flow see Bardy Diagnostics' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Bardy Diagnostics based?
Bardy Diagnostics is headquartered in Seattle.
When was Bardy Diagnostics founded?
Bardy Diagnostics was founded in 2013.